Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Nucleic acid-triggered catalytic drug release.

Z Ma1, J S Taylor

  • 1Department of Chemistry, Washington University, St. Louis, MO 63130, USA.

Proceedings of the National Academy of Sciences of the United States of America
|October 12, 2000
PubMed
Summary

We developed a novel method for targeted chemotherapy using disease-specific genetic material to trigger drug release. This approach enables highly selective cancer treatment by activating cytotoxic agents only at the disease site.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Percutaneous nephrostomy catheter-related infections in patients with gynaecological cancers: a multidisciplinary algorithmic approach.

The Journal of hospital infection·2023
Same author

Montaigne and Medicine.

Annals of medical history·2021
Same author

Montaigne and Medicine.

Annals of medical history·2021
Same author

Montaigne and Medicine.

Annals of medical history·2021
Same author

Hand eczema in children referred for patch testing: North American Contact Dermatitis Group Data, 2000-2016.

The British journal of dermatology·2021
Same author

Clinical outcomes of patients with adenocarcinoma in situ of the cervix treated by conization.

European journal of gynaecological oncology·2015

Area of Science:

  • Biochemistry
  • Molecular Biology
  • Drug Delivery Systems

Background:

  • Current chemotherapeutic agents often lack specificity, leading to off-target toxicity.
  • Targeted drug delivery systems are crucial for improving therapeutic efficacy and reducing side effects.
  • Utilizing genetic information for drug activation offers a promising avenue for precision medicine.

Purpose of the Study:

  • To propose and demonstrate a novel concept for designing highly selective chemotherapeutic agents.
  • To leverage disease-specific genetic information (mRNA or DNA) to trigger the release of cytotoxic drugs.
  • To investigate the feasibility of a prodrug-catalyst system activated by specific nucleic acid sequences.

Main Methods:

  • Development of a model system utilizing the hydrolysis of p-nitrophenyl esters by imidazole.

Related Experiment Videos

  • Synthesis of a catalytic component: imidazole group linked to a 5' oligodeoxynucleotide.
  • Synthesis of a prodrug component: p-nitrophenol ester linked to a 3' oligodeoxynucleotide.

    • Main Results:

    • Demonstrated efficient catalytic release of p-nitrophenol in vitro with the designed system.
    • The system exhibited catalytic activity with multiple turnovers, behaving like an enzyme following Michaelis-Menten kinetics (K(M)=22 µM, k(cat)=0.018 min⁻¹).
    • Catalytic release was highly sensitive to single base-pair mismatches in the triggering sequence, indicating high specificity.

    Conclusions:

    • The proposed concept for genetically triggered drug release is feasible and highly specific.
    • This approach holds significant potential for the rational design of next-generation, targeted chemotherapeutic agents.
    • The system's sensitivity to sequence variations suggests its applicability in distinguishing between healthy and diseased cells based on genetic profiles.